UTAH MEDICAL PRODUCTS INC (UTMD)
US9174881089 - Common Stock
UTMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. UTMD gets an excellent profitability rating and is at the same time showing great financial health properties. UTMD has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
UTMD had positive earnings in the past year.
In the past year UTMD had a positive cash flow from operations.
Each year in the past 5 years UTMD has been profitable.
Each year in the past 5 years UTMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 12.28%, UTMD belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
UTMD has a better Return On Equity (12.97%) than 88.54% of its industry peers.
UTMD has a better Return On Invested Capital (10.43%) than 91.67% of its industry peers.
UTMD had an Average Return On Invested Capital over the past 3 years of 13.10%. This is above the industry average of 8.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.28% | ||
| ROE | 12.97% | ||
| ROIC | 10.43% |
ROA(3y)12.79%
ROA(5y)12.29%
ROE(3y)13.73%
ROE(5y)13.25%
ROIC(3y)13.1%
ROIC(5y)12.62%
1.3 Margins
The Profit Margin of UTMD (33.12%) is better than 98.44% of its industry peers.
In the last couple of years the Profit Margin of UTMD has declined.
With an excellent Operating Margin value of 33.41%, UTMD belongs to the best of the industry, outperforming 98.96% of the companies in the same industry.
In the last couple of years the Operating Margin of UTMD has declined.
UTMD's Gross Margin of 59.80% is in line compared to the rest of the industry. UTMD outperforms 56.25% of its industry peers.
In the last couple of years the Gross Margin of UTMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.41% | ||
| PM (TTM) | 33.12% | ||
| GM | 59.8% |
OM growth 3Y4.14%
OM growth 5Y-3.79%
PM growth 3Y8.96%
PM growth 5Y-5.6%
GM growth 3Y-0.42%
GM growth 5Y-0.92%
2. Health
2.1 Basic Checks
UTMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, UTMD has more shares outstanding
The number of shares outstanding for UTMD has been reduced compared to 5 years ago.
There is no outstanding debt for UTMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
UTMD has an Altman-Z score of 24.03. This indicates that UTMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 24.03, UTMD belongs to the best of the industry, outperforming 96.35% of the companies in the same industry.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 24.03 |
ROIC/WACC1.07
WACC9.72%
2.3 Liquidity
A Current Ratio of 22.56 indicates that UTMD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 22.56, UTMD belongs to the top of the industry, outperforming 99.48% of the companies in the same industry.
UTMD has a Quick Ratio of 20.53. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
UTMD's Quick ratio of 20.53 is amongst the best of the industry. UTMD outperforms 99.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 22.56 | ||
| Quick Ratio | 20.53 |
3. Growth
3.1 Past
UTMD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.09%.
The Earnings Per Share has been decreasing by -1.53% on average over the past years.
UTMD shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
Measured over the past years, UTMD shows a small growth in Revenue. The Revenue has been growing by 3.64% on average per year.
EPS 1Y (TTM)1.09%
EPS 3Y15.87%
EPS 5Y-1.53%
EPS growth Q2Q-6.4%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y5.99%
Revenue growth 5Y3.64%
Revenue growth Q2Q-9.12%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.34, which indicates a correct valuation of UTMD.
UTMD's Price/Earnings ratio is rather cheap when compared to the industry. UTMD is cheaper than 91.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.02, UTMD is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.34 | ||
| Fwd PE | N/A |
4.2 Price Multiples
UTMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UTMD is cheaper than 96.88% of the companies in the same industry.
UTMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UTMD is cheaper than 95.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.63 | ||
| EV/EBITDA | 6.76 |
4.3 Compensation for Growth
UTMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
UTMD has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.
UTMD's Dividend Yield is rather good when compared to the industry average which is at 1.67. UTMD pays more dividend than 96.35% of the companies in the same industry.
UTMD's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
5.2 History
The dividend of UTMD has a limited annual growth rate of 1.69%.
UTMD has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of UTMD decreased recently.
Dividend Growth(5Y)1.69%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
UTMD pays out 25.74% of its income as dividend. This is a sustainable payout ratio.
DP25.74%
EPS Next 2YN/A
EPS Next 3YN/A
UTAH MEDICAL PRODUCTS INC
NASDAQ:UTMD (5/7/2024, 1:24:14 PM)
70.12
+0.73 (+1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap251.73M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.34 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.28% | ||
| ROE | 12.97% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 33.41% | ||
| PM (TTM) | 33.12% | ||
| GM | 59.8% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 22.56 | ||
| Quick Ratio | 20.53 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1.09%
EPS 3Y15.87%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y5.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y